• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CrkL 可有效介导 TGF-β 通路诱导的脑胶质母细胞瘤中的细胞增殖、迁移和侵袭。

CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma.

出版信息

J Mol Neurosci. 2013 Nov;51(3):1046-51. doi: 10.1007/s12031-013-0096-3.

DOI:10.1007/s12031-013-0096-3
PMID:23959425
Abstract

Crk-like (CrkL) is an adapter protein that has crucial roles in cell proliferation, adhesion, and migration. However, the expression pattern and potential mechanism of CrkL protein in glioblastoma multiforme (GBM) have not been fully elucidated. To determine roles of CrkL in cell signaling, proliferation, and migration, small interfering RNAs and plasmids transfection were used to suppress or overexpress CrkL in U87 and U251; soft-agar assay and wound-healing assay were used to observe cell invasiveness, migration, and proliferation. Erk1/2, Smad2, and matrix metalloproteinase 9 (MMP9) were also analyzed by western blot. CrkL was expressed in U87 and U251 cell lines and can be activated by transforming growth factor-beta 1 (TGF-β1) in vitro; CrkL knockdown significantly suppressed the expression of phosph-ERK1/2 and MMP9 but enhanced phosph-Smad2 expression compared with control (p <0.001). Overexpression of CrkL against control upregulated phosph-ERK1/2 and MMP9 and, at the same time, downregulated phosph-Smad2 (p <0.01). On the other hand, CrkL knockdown could significantly affect U87 and U251 invasiveness (p <0.01) and wound closure (p <0.01) using soft-agar assay and wound-healing assay. These studies suggest that CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma. Furthermore, CrkL can be used as a potential and efficient therapeutic target of GBM and may also mediate other signaling pathway.

摘要

卷曲相关蛋白(CrkL)是一种衔接蛋白,在细胞增殖、黏附和迁移中发挥着关键作用。然而,CrkL 蛋白在多形性胶质母细胞瘤(GBM)中的表达模式和潜在机制尚未完全阐明。为了确定 CrkL 在细胞信号转导、增殖和迁移中的作用,使用小干扰 RNA 和质粒转染来抑制或过表达 U87 和 U251 中的 CrkL;使用软琼脂测定和划痕愈合测定来观察细胞侵袭、迁移和增殖。还通过 Western blot 分析 Erk1/2、Smad2 和基质金属蛋白酶 9(MMP9)。CrkL 在 U87 和 U251 细胞系中表达,并且可以在体外被转化生长因子-β1(TGF-β1)激活;与对照相比,CrkL 敲低显著抑制了磷酸化-Erk1/2 和 MMP9 的表达,但增强了磷酸化-Smad2 的表达(p<0.001)。与对照相比,CrkL 的过表达上调了磷酸化-Erk1/2 和 MMP9,同时下调了磷酸化-Smad2(p<0.01)。另一方面,CrkL 敲低可以显著影响 U87 和 U251 的侵袭性(p<0.01)和划痕愈合(p<0.01),使用软琼脂测定和划痕愈合测定。这些研究表明,CrkL 有效地介导了 TGF-β 通路在胶质母细胞瘤中诱导的细胞增殖、迁移和侵袭。此外,CrkL 可以作为 GBM 的潜在和有效治疗靶点,也可能介导其他信号通路。

相似文献

1
CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma.CrkL 可有效介导 TGF-β 通路诱导的脑胶质母细胞瘤中的细胞增殖、迁移和侵袭。
J Mol Neurosci. 2013 Nov;51(3):1046-51. doi: 10.1007/s12031-013-0096-3.
2
Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma.在胶质母细胞瘤中,核仁素通过转化生长因子-β受体I促进转化生长因子-β信号的起始。
J Mol Neurosci. 2015 Jan;55(1):1-6. doi: 10.1007/s12031-014-0292-9. Epub 2014 Apr 1.
3
Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.Crk样衔接蛋白是上皮性卵巢癌中转化生长因子-β诱导的AKT和ERK信号通路所必需的。
Tumour Biol. 2015 Feb;36(2):915-9. doi: 10.1007/s13277-014-2724-0. Epub 2014 Oct 12.
4
Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.定量评估体外脑胶质瘤表型可将细胞迁移作为 Crk 和 CrkL 活性的可靠读出。
J Biol Chem. 2021 Jan-Jun;296:100390. doi: 10.1016/j.jbc.2021.100390. Epub 2021 Feb 6.
5
The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma.微小RNA-146a的下调调节胶质母细胞瘤中的转化生长因子-β信号通路活性。
Mol Neurobiol. 2015 Dec;52(3):1257-1262. doi: 10.1007/s12035-014-8938-8. Epub 2014 Oct 19.
6
Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.Crk样衔接蛋白通过上皮性卵巢癌中的ERK信号通路调节CCL19/CCR7介导的上皮-间质转化。
Med Oncol. 2015 Mar;32(3):47. doi: 10.1007/s12032-015-0494-1. Epub 2015 Jan 31.
7
CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways.CrkL通过平衡Erk1/2和PI3K/Akt信号通路来调控基质细胞衍生因子-1诱导的乳腺癌生物学行为。
Med Oncol. 2015 Jan;32(1):411. doi: 10.1007/s12032-014-0411-z. Epub 2014 Dec 5.
8
CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.CRKL过表达抑制小鼠肝癌Hca-P细胞的体外增殖、侵袭和迁移。
Biomed Pharmacother. 2015 Feb;69:11-7. doi: 10.1016/j.biopha.2014.10.025. Epub 2014 Nov 4.
9
CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.CrkL调控胃癌中CCL20/CCR6诱导的上皮-间质转化。
Cytokine. 2015 Dec;76(2):163-169. doi: 10.1016/j.cyto.2015.05.009. Epub 2015 Jun 1.
10
MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.丝裂原活化蛋白激酶相互作用激酶 1 调控人胶质母细胞瘤中 SMAD2 依赖的 TGF-β信号通路。
Cancer Res. 2011 Mar 15;71(6):2392-402. doi: 10.1158/0008-5472.CAN-10-3112. Epub 2011 Mar 14.

引用本文的文献

1
The p130Cas-Crk/CrkL Axis: A Therapeutic Target for Invasive Cancers Unveiled by Collaboration Among p130Cas, Crk, and CrkL.p130Cas-Crk/CrkL轴:p130Cas、Crk和CrkL合作揭示的侵袭性癌症治疗靶点
Int J Mol Sci. 2025 Apr 24;26(9):4017. doi: 10.3390/ijms26094017.
2
Genetic alterations of GI-NECs involving three main signaling pathways.涉及三条主要信号通路的 GI-NEC 遗传改变。
Cancer Med. 2023 Apr;12(7):8238-8250. doi: 10.1002/cam4.5633. Epub 2023 Jan 18.
3
Crk and CrkL as Therapeutic Targets for Cancer Treatment.Crk 和 CrkL 作为癌症治疗的治疗靶点。

本文引用的文献

1
Models of crk adaptor proteins in cancer.癌症中Crk衔接蛋白的模型。
Genes Cancer. 2012 May;3(5-6):341-52. doi: 10.1177/1947601912459951.
2
TGF-β as a therapeutic target in high grade gliomas - promises and challenges.TGF-β 作为高级别脑胶质瘤的治疗靶点——前景与挑战。
Biochem Pharmacol. 2013 Feb 15;85(4):478-85. doi: 10.1016/j.bcp.2012.11.005. Epub 2012 Nov 14.
3
SHP-1 protein tyrosine phosphatase associates with the adaptor protein CrkL.SHP-1 蛋白酪氨酸磷酸酶与衔接蛋白 CrkL 结合。
Cells. 2021 Mar 27;10(4):739. doi: 10.3390/cells10040739.
4
Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.定量评估体外脑胶质瘤表型可将细胞迁移作为 Crk 和 CrkL 活性的可靠读出。
J Biol Chem. 2021 Jan-Jun;296:100390. doi: 10.1016/j.jbc.2021.100390. Epub 2021 Feb 6.
5
miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells Targeting CRKL.miR-124-3p通过靶向CRKL抑制肝癌细胞的侵袭和转移
Front Mol Biosci. 2020 Sep 15;7:223. doi: 10.3389/fmolb.2020.00223. eCollection 2020.
6
Evaluation of rs1982073 polymorphism of transforming growth factor-β1 in glioblastoma.胶质母细胞瘤中转化生长因子-β1的rs1982073多态性评估
J Res Med Sci. 2019 May 22;24:40. doi: 10.4103/jrms.JRMS_850_18. eCollection 2019.
7
MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.miRNA 靶标网络分析鉴定乙型肝炎肝硬化中医证候发展评价的潜在生物标志物。
Sci Rep. 2017 Sep 8;7(1):11054. doi: 10.1038/s41598-017-11351-5.
8
Identification of potential key genes associated with glioblastoma based on the gene expression profile.基于基因表达谱鉴定与胶质母细胞瘤相关的潜在关键基因。
Oncol Lett. 2017 Aug;14(2):2045-2052. doi: 10.3892/ol.2017.6460. Epub 2017 Jun 22.
9
CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma.CRKL过表达促进子宫内膜癌细胞增殖并抑制其凋亡。
Oncol Lett. 2017 Jan;13(1):51-56. doi: 10.3892/ol.2016.5394. Epub 2016 Nov 17.
10
Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.转录谱分析和miRNA-靶标网络分析鉴定扶正化瘀方治疗乙型肝炎肝硬化疗效评估的潜在生物标志物。
Int J Mol Sci. 2016 Jun 3;17(6):883. doi: 10.3390/ijms17060883.
Exp Hematol. 2012 Dec;40(12):1055-9. doi: 10.1016/j.exphem.2012.08.007. Epub 2012 Sep 5.
4
The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer.CRKL 基因编码一种衔接蛋白,在胃癌中扩增、过表达,并可能成为治疗靶点。
J Transl Med. 2012 Jul 3;10:97. doi: 10.1186/1479-5876-10-97.
5
Emerging roles for crk in human cancer.Crk在人类癌症中的新作用。
Genes Cancer. 2010 Nov;1(11):1132-9. doi: 10.1177/1947601910397188.
6
p53 and its mutants in tumor cell migration and invasion.p53 及其突变体在肿瘤细胞迁移和侵袭中的作用。
J Cell Biol. 2011 Jan 24;192(2):209-18. doi: 10.1083/jcb.201009059.
7
Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk.茶黄素通过 p53-ROS 相互作用抑制 NF-κB 从而抑制人乳腺癌细胞迁移。
FEBS Lett. 2010 Jan 4;584(1):7-14. doi: 10.1016/j.febslet.2009.10.081.
8
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.Crk 和 CrkL 衔接蛋白:生理和病理信号的网络。
Cell Commun Signal. 2009 May 10;7:13. doi: 10.1186/1478-811X-7-13.
9
Nucleocytoplasmic shuttling of Smad proteins.Smad蛋白的核质穿梭
Cell Res. 2009 Jan;19(1):36-46. doi: 10.1038/cr.2008.325.
10
Malignant gliomas in adults.成人恶性胶质瘤
N Engl J Med. 2008 Jul 31;359(5):492-507. doi: 10.1056/NEJMra0708126.